SBBP
Strongbridge Biopharma plc.
SBBP
SBBP
Delisted
SBBP was delisted on the 5th of October, 2021.
54 hedge funds and large institutions have $64.8M invested in Strongbridge Biopharma plc. in 2019 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 23 increasing their positions, 13 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
54
Holders Change
-4
Holders Change %
-6.9%
% of All Funds
1.19%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
7
Increased
23
Reduced
13
Closed
11
Calls
$6K
Puts
–
Net Calls
+$6K
Net Calls Change
–
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$1.14M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$903K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$728K |
| 4 |
BlackRock
New York
|
+$547K |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$514K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
-$4.95M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.55M |
| 3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$508K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$376K |
| 5 |
Jane Street
New York
|
-$257K |
